Cyclin E-CDK2 regulates cancer cell transcriptional program and response to immunotherapy through BRD4
Chu et al. show that cyclin E-CDK2 has a cell-cycle-independent role in transcriptional regulation by phosphorylating BRD4 and controlling its chromatin occupancy.